RRMGX
Price
$84.36
Change
-$5.84 (-6.47%)
Updated
Feb 3 closing price
Net Assets
25.1B
TAAGX
Price
$15.51
Change
+$1.30 (+9.15%)
Updated
Feb 3 closing price
Net Assets
106.12M
Interact to see
Advertisement

RRMGX vs TAAGX

Header iconRRMGX vs TAAGX Comparison
Open Charts RRMGX vs TAAGXBanner chart's image
T. Rowe Price Mid-Cap Growth R
Price$84.36
Change-$5.84 (-6.47%)
VolumeN/A
Net Assets25.1B
Timothy Plan Small/Mid Cap Growth Cl A
Price$15.51
Change+$1.30 (+9.15%)
VolumeN/A
Net Assets106.12M
RRMGX vs TAAGX Comparison Chart in %
View a ticker or compare two or three
VS
RRMGX vs. TAAGX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RRMGX is a Hold and TAAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 25.1B vs. TAAGX (106M). RRMGX (0.00) and TAAGX (0.00) have matching dividends . RRMGX was incepted earlier than TAAGX: RRMGX (23 years) vs TAAGX (25 years). TAAGX (1.59) is less costly to investors than RRMGX (1.29). TAAGX is a more actively managed with annual turnover of: 74.00 vs. RRMGX (22.60). TAAGX has a lower initial minimum investment than RRMGX: TAAGX (1000) vs RRMGX (2500). TAAGX annual gain was more profitable for investors over the last year : 23.98 vs. RRMGX (-7.22). TAAGX return over 5 years is better than : 31.59 vs. RRMGX (-21.55).
RRMGXTAAGXRRMGX / TAAGX
Total Expense Ratio1.291.4987%
Annual Report Gross Expense Ratio1.291.5981%
Fund Existence23 years25 years-
Gain YTD-0.18912.229-2%
Front LoadN/A6%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets25.1B106M23,679%
Annual Yield % from dividends0.000.00-
Returns for 1 year-7.2223.98-30%
Returns for 3 years-4.1058.59-7%
Returns for 5 years-21.5531.59-68%
Returns for 10 years37.39165.6623%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOVFF1.290.05
+3.78%
Cannara Biotech Inc.
SCCFF0.22N/A
N/A
Strategic Resources Inc.
MAUSY11.85N/A
N/A
Matsui Securities Co. Ltd.
AKBLF36.10N/A
N/A
Alk Abello AS
SEMHF51.40-0.19
-0.38%
Siemens Healthineers AG